The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Natera
Stock and Other Ownership Interests - Natera
Circulating tumor DNA analysis for assessment of recurrence risk, benefit of adjuvant therapy, and early relapse detection after treatment in colorectal cancer patients.
 
Tenna V Henriksen
No Relationships to Disclose
 
Noelia Tarazona
No Relationships to Disclose
 
Thomas Reinert
No Relationships to Disclose
 
Juan Antonio Carbonell-Asins
No Relationships to Disclose
 
Derrick Renner
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Shruti Sharma
No Relationships to Disclose
 
Desamparados Roda
No Relationships to Disclose
 
Marisol Huerta
No Relationships to Disclose
 
Susana Roselló
No Relationships to Disclose
 
Lene H. Iversen
No Relationships to Disclose
 
Kåre Andersson Gotschalck
No Relationships to Disclose
 
Anders Husted Madsen
No Relationships to Disclose
 
Per Vadgaard Andersen
No Relationships to Disclose
 
Ole Thorlacius-Ussing
No Relationships to Disclose
 
Uffe S. Løve
No Relationships to Disclose
 
Himanshu Sethi
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Patents, Royalties, Other Intellectual Property - Patents
Travel, Accommodations, Expenses - Natera
 
Alexey Aleshin
Employment - Natera; Natera
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Mission Bio; Mission Bio
 
Andres Cervantes
Consulting or Advisory Role - Bayer (Inst); Pierre Fabre (Inst)
Speakers' Bureau - Merck Serono (Inst); Roche (Inst); SERVIER (Inst)
Research Funding - Abbvie (Inst); Amcure (Inst); Array BioPharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Johnson & Johnson (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Sierra Oncology (Inst); Takeda (Inst); Tesaro (Inst); Theradex (Inst)
Travel, Accommodations, Expenses - Roche
 
Claus Lindbjerg Andersen
No Relationships to Disclose